PR Newswire Asia's news

 < Previous page   |   Detail   |   Print    Next page > 
     
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
MAKER'S MARK LAUNCHES AIRPORT-EXCLUSIVE ARTIST SERIES
2026-07-15T    Art   Beer, Wine & Spirits   Beverages   Retail 
IBM Launches New Power Systems and Software Built for Enterprises to Address Risk, Productivity, and Flexibility
2026-07-15T    Computer Software   Computer/Electronics   Peripherals 
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Kelun-Biotech and Harbour BioMed Announce NMPA Approval of IND Application for SKB575/HBM7575 for the Treatment of Asthma
2026-07-15T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
/C O R R E C T I O N -- Hoymiles Power Electronics Inc./
2026-07-15T    Alternative Energies   Computer/Electronics   Green Technology   Oil/Energy 
/C O R R E C T I O N -- CLASSYS/
2026-07-15T    Computer/Electronics   Consumer Electronics 
Solos Unveils Next-Generation AirGo™ A6 and New Privacy Kit, Launches AirGo™ V2 Worldwide at Third Annual AI Smartglasses Symposium in Hong Kong
2026-07-15T    Consumer Electronics   Trade show news 
Gausium Ranked World's No.1 Commercial Cleaning Robot Supplier by IDC, Shifting From Flagship Wins to Scalable Growth
2026-07-15T    Computer/Electronics   Consumer Electronics 
ATFX Launches World Trading Cup, Bringing Regional Trading Competitions to a Global Stage
2026-07-15T    Banking/Financial Service   Computer/Electronics   Trade show news 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.